Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at [email protected]
The 7th Annual Allogeneic Cell Therapies Summit
Making Safe, Durable & Effective Universal Cell Therapies a Reality
Following fast-track designations for Imugene, landmark Phase 2 data from Orca Bio and with growing traction in HLA-matching strategies, the Chief Executive Officer at OneChain Immunotherapies is right to suggest that the allogeneic products are ‘poised for prime time.’
In 2025, you united with 80+ experts at the 7th Annual Allogeneic Cell Therapies Summit, to address critical challenges in optimizing complex gene engineering, upscaling cell production and navigating the regulatory landscape, to bring these transformative off-the-shelf therapies to market.
Attendees brainstormed with industry experts at Adicet Bio, Takeda, AstraZeneca, Cellectis, Caribou Biosciences and more, to develop effective strategies that demonstrated the potential of off-the-shelf therapies for patients in need.
"This meeting is THE place to discuss opportunities and challenges in allogeneic cell therapies”
SmartImmune, 2025 Speaker
Our 2025 Speaker Faculty Featured
Past Attending Companies Included
"This was the first conference I attended, and I had a great time. I enjoyed how friendly and collaborative everyone was. It was an environment where everyone could come together and discuss and learn together regardless of background”
Sana Biotechnology, 2024 Attendee
2025 Partners
Lead Partner
Expertise Partner
Program Partners
Innovation Partner
Hosting Partners
Exhibition Partners
Event Partner
"The incredible diversity of technologies and the true innovation delivered by multiple biotechs in the allogeneic field are very promising, and are hopeful to ensure progress in this sector”
NKILT Therapeutics, 2025 Speaker